2, 4 - diaminopyrimidines and their use for inducing cardiomyogenesis

Details for Australian Patent Application No. 2005205167 (hide)

Owner The Scripps Research Institute Novartis AG

Inventors Schultz, Peter G.; Ding, Sheng; Wu, Xu

Agent Davies Collison Cave

Pub. Number AU-A-2005205167

PCT Pub. Number WO2005/068437

Priority 60/537,144 16.01.04 US

Filing date 14 January 2005

Wipo publication date 28 July 2005

International Classifications

C07D 239/48 (2006.01) Heterocyclic compounds containing 1,3-diazine or hydrogenated 1,3-diazine rings

C07D 403/12 (2006.01) Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, not provided for by group

C07D 405/12 (2006.01) Heterocyclic compounds containing both one or more hetero rings having oxygen atoms as the only ring hetero atoms, and one or more rings having nitrogen as the only ring hetero atom

Event Publications

13 July 2006 PCT application entered the National Phase

  PCT publication WO2005/068437 Priority application(s): WO2005/068437

8 October 2009 Application Lapsed, Refused Or Withdrawn, Patent Ceased or Expired

  This application lapsed under section 142(2)(e). Examination has been requested or an examination report has issued for this application. Note that applications or patents shown as lapsed or ceased may be restored at a later date.

Legal

The information provided by the Site not in the nature of legal or other professional advice. The information provided by the Site is derived from third parties and may contain errors. You must make your own enquiries and seek independent advice from the relevant industry professionals before acting or relying on any information contained herein. Check the above data against the Australian Patent Office AUSPAT database.

Next and Previous Patents/Applications

2005205175-Exhaust gas regenerator comprising a catalyst

2005205166-Pharmaceutical compositions comprising higher primary alcohols and ezetimibe and process of preparation thereof